Form 4/A for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-11-07 00:00:00 ET · period of report 2022-10-05 · accession 0000899243-22-035333 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2022-11-07 | 2022-10-06 | DNA | Dmytruk Mark E. | See remarks | S - Sale+OE | $3.25 | -279.3K | 348.1K | -45% | -$907.6K |
| DA | 2022-11-07 | 2022-10-05 | DNA | Dmytruk Mark E. | See remarks | M - OptEx | — | +618.2K | 627.3K | +6,792% | — |
| DA | 2022-11-07 | 2022-10-05 | DNA | Dmytruk Mark E. | See remarks | M - OptEx | — | -618.2K | 1.90M | -25% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-10-06 | S | D | 279,255 | $3.25 | 348,089 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-10-05 | M | A | 618,242 | — | 627,344 | D | — | — | (F1) Represents the conversion of shares of Restricted Stock Units ("RSUs") to Class A Common Stock. On October 5, 2022, the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for 618,242 vested RSUs. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. |
| 3 | Derivative | Restricted Stock Units | 2022-10-05 | M | D | 618,242 | — | 1,899,021 | D | — · — to — | — Class A Common Stock | (F1) Represents the conversion of shares of Restricted Stock Units ("RSUs") to Class A Common Stock. On October 5, 2022, the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for 618,242 vested RSUs. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. (F3) On March 14, 2022, the Reporting Person filed a Form 4 that reported RSUs on a consolidated basis with holdings of Class B Common Stock. Because the Issuer has the ability to settle such RSUs with shares of Class A Common Stock or cash upon vesting, RSUs will be reported separately from shares of Class B Common Stock in future reports. In addition to the RSUs reported herein, the Reporting Person beneficially owns 658,133 shares of Class B Common Stock, which includes shares of Class B Common Stock that are subject to vesting conditions. |